Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chris Heberlig currently holds 42,991 shares of SYNAGEVA BIOPHARMA CORP (GEVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chris Heberlig has been a net seller of GEVA stock. They have purchased $0 and sold $2.8M worth of shares.
Chris Heberlig's most recent insider trade was on May 29, 2018, when they sold 6,392 shares at $0.00 per share.
Chris Heberlig serves as Executive at SYNAGEVA BIOPHARMA CORP (GEVA). They have executed 47 insider transactions totaling $2.8M over their tenure at the company.
Chris Heberlig holds the position of Executive at SYNAGEVA BIOPHARMA CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Chris Heberlig has shown a selling trading pattern, with $0 in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Chris Heberlig was on Mar 12, 2014, when they sold $387.4K worth of GEVA shares. This transaction involved 3,933 shares at $98.49 per share.
Chris Heberlig currently owns 42,991 shares of SYNAGEVA BIOPHARMA CORP (GEVA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chris Heberlig's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chris Heberlig has 47 Form 4 filings on record as an insider at SYNAGEVA BIOPHARMA CORP.
Set alerts for Chris Heberlig and 40,000+ other insiders.